The Effects of Azithromycin Ophthalmic Solution, 1% Versus(vs) Placebo on Subjects With Blepharitis During a Two-Week Treatment Period.

Trial Profile

The Effects of Azithromycin Ophthalmic Solution, 1% Versus(vs) Placebo on Subjects With Blepharitis During a Two-Week Treatment Period.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Sep 2011

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Infectious blepharitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2010 Merck as company and lead trial centre added as reported by ClinicalTrials.gov.
    • 01 Nov 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.
    • 01 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top